Theravance Biopharma
TBPH
#6852
Rank
โ‚ฌ0.45 B
Marketcap
Country
9,18ย โ‚ฌ
Share price
-1.44%
Change (1 day)
-8.28%
Change (1 year)

Revenue for Theravance Biopharma (TBPH)

Revenue in 2024 (TTM): โ‚ฌ57.71 Million

According to Theravance Biopharma 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ60.51 Million. In 2023 the company made a revenue of โ‚ฌ51.94 Million an increase over the revenue in the year 2022 that were of โ‚ฌ47.86 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Theravance Biopharma from 2013 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ57.71 M11.11%
2023 โ‚ฌ51.94 M8.52%
2022 โ‚ฌ47.86 M-1.99%
2021 โ‚ฌ48.83 M-16.4%
2020 โ‚ฌ58.42 M-10.86%
2019 โ‚ฌ65.53 M24.19%
2018 โ‚ฌ52.77 M311.53%
2017 โ‚ฌ12.82 M-72.27%
2016 โ‚ฌ46.24 M20.04%
2015 โ‚ฌ38.52 M300.9%
2014 โ‚ฌ9.61 M5772.47%
2013 โ‚ฌ0.16 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ0.57 B 848.29%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.60 B 894.67%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.44 B 628.70%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ4.23 B 6,897.72%๐Ÿ‡บ๐Ÿ‡ธ USA